20208473

Source:http://linkedlifedata.com/resource/pubmed/id/20208473

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033860, umls-concept:C1608841, umls-concept:C2702169
pubmed:issue	1330
pubmed:dateCreated	2010-3-8
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985240R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Dermatologic Agents, http://linkedlifedata.com/resource/pubmed/chemical/ustekinumab
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1523-2859
pubmed:issnType	Electronic
pubmed:day	25
pubmed:volume	52
pubmed:owner	NLM
pubmed:pagination	7-8
pubmed:dateRevised	2011-7-29
pubmed:meshHeading	pubmed-meshheading:20208473-Antibodies, Monoclonal, pubmed-meshheading:20208473-Dermatologic Agents, pubmed-meshheading:20208473-Humans, pubmed-meshheading:20208473-Neoplasms, pubmed-meshheading:20208473-Posterior Leukoencephalopathy Syndrome, pubmed-meshheading:20208473-Psoriasis, pubmed-meshheading:20208473-Severity of Illness Index, pubmed-meshheading:20208473-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Ustekinumab (Stelara) for psoriasis.
pubmed:publicationType	Journal Article